Ever wonder why a CBD product that does a lot for your friend barely registers for you? New research suggests genetics could be part of the answer.
According to The Marijuana Herald, researchers from Purdue University and the Indiana University School of Medicine presented a study Oct. 14 at the 2026 American Conference on Pharmacometrics. They analyzed 540 blood measurements from 30 healthy adults who took oral CBD at 5 milligrams per kilogram of body weight, looking at both a single dose and repeated dosing.
The team built a model of how CBD is absorbed, spread through the body and cleared. They found preliminary evidence that a person's CYP2C19 status, meaning how efficiently a common enzyme that also processes many medications works for them, may influence how CBD is processed. They also saw that the timing of absorption shifted between a single dose and repeated doses, and that clearance varied a lot from person to person.
The researchers stressed this is an early step. Next, they plan a formal analysis of genetic and other factors and want to add CBD's breakdown products to the model.
What it means for travelers: Labels list milligrams, but your body decides how they land. If you're trying CBD somewhere new, start low, give it time, and don't stack doses. Because the same enzyme handles many medications, talk to a pharmacist or doctor if you take any.






